Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2017

01-02-2017 | Clinical Practice: Clinical Images

Approaching End-of-Life with Aplomb and Plombage

Author: Benjamin T. Galen, M.D.

Published in: Journal of General Internal Medicine | Issue 2/2017

Login to get access

Excerpt

An 84-year-old gentleman was admitted with complications from lung adenocarcinoma. He had a remote history of pulmonary tuberculosis, and was status post plombage of the right upper thorax (Fig. 1). Based on the observation that patients with pulmonary tuberculosis were apparently cured after a spontaneous pneumothorax, methyl-methacrylate (Lucite) balls were used in the early to mid-twentieth century to collapse the infected lung, a practice known as Lucite-ball plombage.1 Late complications of plombage include infection, fistulization, ball fractures, cancer involving the balls, and even migration outside the thoracic cavity.2 , 3 Lucite-ball plombage was eventually deemed antiquated due to high complication rates and the advent of effective antituberculosis medications. This patient’s anterior mediastinal adenocarcinoma had been diagnosed three years prior without clear connection to the plombage cavity, deemed unresectable, and was treated with palliative chemotherapy and radiation (Fig. 2). The air/fluid level seen in one of the thoracic balls was unchanged for many years (Fig. 2, white asterisk). He died of sepsis after electing for comfort care.
Literature
2.
go back to reference Yadav S, Sharma H, Iyer A. Late extrusion of pulmonary plombage outside the thoracic cavity. Interact Cardiovasc Thorac Surg. 2010;10:808–10.CrossRefPubMed Yadav S, Sharma H, Iyer A. Late extrusion of pulmonary plombage outside the thoracic cavity. Interact Cardiovasc Thorac Surg. 2010;10:808–10.CrossRefPubMed
3.
go back to reference Gotoh S, Chohnabayashi N. Infection 57 years after plombage. NEJM. 2009;360:23.CrossRef Gotoh S, Chohnabayashi N. Infection 57 years after plombage. NEJM. 2009;360:23.CrossRef
Metadata
Title
Approaching End-of-Life with Aplomb and Plombage
Author
Benjamin T. Galen, M.D.
Publication date
01-02-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3828-6

Other articles of this Issue 2/2017

Journal of General Internal Medicine 2/2017 Go to the issue

Letter to the Editor

Comparing VA to Non-VA Care

Clinical Practice: Clinical Images

Bullosis Diabeticorum

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.